A B S T R A C T Intestinal absorption of the monoglutamate form of the principal dietary and circulating folate compound, 5-methyltetrahydrofolic acid (5-MTHF), was studied in the rat utilizing a synthetic highly purified radiolabeled diastereoisomer. Chromatography confirmed that the compound was not altered after transfer from the mucosa to the serosa. Accumulation against a concentration gradient was not observed in duodenal, jejunal, or ileal segments at 5-MTHF concentration from 0.5 to 500 nmoles/liter. Unidirectional transmural flux determination also did not indicate a significant net flux. Mucosal to serosal transfer of 5-MTHF was similar in all segments of the intestine and increased in a linear fashion with increased initial mucosal concentrations. Further, no alteration in 5-MTHF transfer was found when studied in the presence of metabolic inhibitors or folate compounds.
experimental data and conflicting results have prevented an adequate understanding of the problem. Most previous studies have been devoted to the absorption of either folic acid (FA) or FA polyglutamates (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . However, the predominant circulating and storage forms of folate are neither FA nor FA polyglutamates but rather reduced forms of folate, principally 5-methyltetrahydrofolic acid (5-MTHF) (11) . Moreover, the principal dietary folate compound is probably also 5-MTHF or polyglutamate forms of 5-MTHF (12) . Therefore, understanding of folate absorption requires investigation of the absorption of 5-MTHF and 5-MTHF polyglutamates.
In this communication we report our studies of the absorption of 5-MTHF. The synthesis of the physiologically active diastereoisomer of radiolabeled 5-MTHF in our laboratory has facilitated these studies in the rat.
METHODS
Materials. FA,2 labeled by tritium at the 3'-, 5'-, and 9'-positions with a specific activity of 250 MCi/Almole, L-alanine-14C3 and formaldehyde-'4C were obtained commercially. The tritium-labeled physiologically active diastereoisomer of 5-MTHF was prepared as previously published (13) . Briefly, tritium-labeled FA was reduced chemically to dihydrofolic acid (DHF) using the method of Blakley (14) . The DHF was then enzymatically reduced to tetrahydrofolic acid (THF) by a highly purified dihydrofolate reductase (15) . The N-5,10-methylene derivative was prepared from THF by the addition of formaldehyde, and reduced to 5-MTHF by sodium borohydride. 5-MTHF-'4C was prepared in the same manner except unlabeled FA was used as the starting material, and formaldehyde-'4C was added to introduce the label on the methyl group. The radiolabeled compounds were purified by column chromatography, first on A-25 DEAE-Sephadex then on Sephadex G-25. The purified maglutamates, folic acid polyglutamates (usually 3-to 7-glutamates); 5-fTHF, 5-formyltetrahydrofolic acid; 10-fTHF, 10 Intestinial absorption studies in zitro. Absorption was studied by several methods: everted sacs (17) , mucosal scrapings (18) , and unidirectional transmural fluxes (19) in male, albino Sprague-Dawley rats weighing 250-350 g.
Everted gut sacs were prepared according to the method of Wilson and Wiseman (17) , modified as previously described (20) . The buffer system utilized consisted of 122 mm sodium chloride, 4.9 mm KCl, 26.5 mm sodium bicarbonate, and 1.2 mm potassium phosphate, pH 7.4. Each sac was approximately 10 cm long, and its wet weight was approximately 500 mg. The most proximal small intestinal segment was duodenum. The jejunal sacs were the next three segments; the ileal sacs were the three most distal segments. 1 ml of the buffer was placed inside the sac, which was then placed in a flask containing 5 ml of buffer solution and varying concentrations of 5-MTHF and approximately min. In one series of experiments in which anaerobic incubation conditions were desired, nitrogen replaced the O0-C02 gas mixture. At the end of the incubation period, each sac was removed, and the serosal fluid drained by gravity. The wet weight of each sac was determined. In those experiments in which 5-MTHF was not initially present in the serosal media, the serosal sample was diluted to 2.0 ml, and a portion was added to Bray's solution and counted in a Packard Tri-Carb three-channel liquid scintillation spectrometer with automatic external standardization. In these studies, 5-MTHF transfer, expressed in pg/50 min per 0.5 g wt tissue weight, is defined as the amount of 5-MTHF present in the serosal solution at the end of the incubation. In those experiments in which an equal concentration of 5-MTHF was present initially in both the mucosa and serosa solutions, portions of the final mucosal and serosal solutions were also counted. The mucosal to serosal ratio of 5-MTHF was then determined. The transport of 5 mM L-alanine was also determined in a series of experiments to demonstrate active transport in this preparation.
Mucosal scrapings were prepared for incubation as described by Schultz, Fuisz, and Curran (18) (22) .
RESULTS
Identification of transported folate compounds. When everted jejunal sacs were incubated in mucosal media containing 5-MTHF-3H, 14C (500 nmoles/liter), the radiolabels were recovered unchanged from the serosal media after 60 min of incubation (Fig. 1) lar in everted sacs of duodenum, jejunum,, and ileum (Fig. 3) . The increase in transfer at 0.05 ,umole/liter in jejunal segments as compared with duodenal and ileal segments was not statistically significant. The effect of a 1000-fold increment in substrate concentration (0.05-50 'moles/liter) on transfer of 5-MTHF from mucosa to serosa of the duodenum, jejunum, and ileum was to produce a linear increase in the total amount transferred (Fig. 3) .
Effect of modified incubation conditions on 5-MTHF transfer. Everted jejunal sacs were incubated in a mucosal media containing 50 nm 5-MTHF under anaerobic conditions, in a sodium-free medium, and in the presence of 10'M dinitrophenol. No significant decrease in mucosal to serosal transfer was observed as compared with paired controls. 500 nM 5-MTHF transfer in the presence of 10 mm glucose was similar to controls (Fig.   4) .
Effect of folate analogues on 5-MTHF transfer. Everted jejunal sacs were incubated in a mucosal media containing 50 nm 5-MTHF and with 500 nm FA, 500 nM 5-fTHF, or 500 nM methotrexate (MTX). No significant decrease in mucosal to serosal transfer was noted in those tissues incubated with FA and MTX. A significant increase in transfer of 5-MTHF was noted during incubation with 5-fTHF (P < 0.05) (Fig. 5) . (5) originally suggested that the apparent accumulation of FA against a concentration gradient could be accounted for by the conversion of FA to reduced folate by hamster jejunum. Additional evidence of the reduction and methylation by FA by the intestinal mucosa has been observed in rat (24) , and in man (9, 25) , although reduction and methylation of FA by the human intestine has been disputed (26) . Whether these differences are explained by species and concentration differences is not known, but the question requires further study. FA, however, is not the major dietary form of folate. Analysis of liver, pea seedlings, yeast, and milk, indicates that significant amounts of reduced folate, primarily 5-MTHF, are found (11, (27) (28) (29) . Further, analytical methods would tend to underestimate the reduced folate forms, and some of these reduced forms may exist as polyglutamates (12) .
Synthesis of highly purified, radiolabeled 5-MTHF in our laboratory has facilitated the study of the absorption of this physiologic folate compound, 5-MTHF (13) . Intestinal absorption of 5-MTHF was studied in the rat by several different in vitro methods: everted intestinal sacs, mucosal scrapings, and unidirectional transmural fluxes. These investigations indicate that 5-MTHF is transferred unchanged across the rat small intestine and suggest that the mechanism of 5-MTHF absorption is a nonenergy dependent process. These conclusions are supported by (a) the failure to demonstrate movement of 5-MTHF against a concentration gradient in the everted sac experiments, lack of accumulation of 5-MTHF within the intestinal mucosa in mucosal scraping, and no net flux of 5-MTHF in the unidirectional transmural flux studies; (b) the absence of saturation kinetics in that an increase in 5-MTHF mucosal to serosal transfer was linearly related to increased mucosal concentration of 5-MTHF; (c) the inability to inhibit the rate of 5-MTHF transfer with either nitrogen replacement or the addition of a metabolic inhibitor, dinitrophenol; and (d) the failure to inhibit 5-MTHF transfer significantly with folate analogues, FA and MTX. A preferential site of 5-MTHF absorption in the small intestine was not observed. Absorption was quantitatively similar in the duodenum, jejunum, and ileum.
These studies in the rat were performed in vitro and must be confirmed in man before our conclusions can be extended. Although it is conceivable that at lower 5-MTHF concentrations a carrier-mediated system might be identified, it is doubtful that folate concentrations below those used in these studies would have physiologic significance.
The stimulation of 5-MTHF transfer by 5-fTHF is unexplained. However, Goldman (30) recently reported that in L 1210 cells, the presence of 5-fTHF intracellularly will stimulate both 5-MTHF and MTX influx. He has suggested that this observation could be explained by counter flow or counter transport. It would be intriguing to speculate that a similar mechanism exists in the gut. However, our studies do not indicate the presence of a carrier-mediated system in the small intestine. 
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